Ticker League

Free Cash Flow for Biogen (BIIB)

As of · Reported

Metric

Latest period

$2.62B

YoY change

-18.5%

5Y CAGR

-11.6%

Peak year (2019)

$6.56B

Free Cash Flow history chart for Biogen (BIIB) from 1989 to 2025

Latest: $2.05B

Free Cash Flow growth chart for Biogen (BIIB) from 1989 to 2025

Latest: -18.5%

Free Cash Flow history table for Biogen (BIIB) from 1989 to 2025

  • 2025$2.05B-18.5%
  • 2024$2.52B+103.6%
  • 2023$1.24B+8.0%
  • 2022$1.14B-66.2%
  • 2021$3.38B-11.1%
  • 2020$3.81B-42.0%
  • 2019$6.56B+23.8%
  • 2018$5.30B+43.9%
  • 2017$3.68B-4.6%
  • 2016$3.86B+25.6%
  • 2015$3.07B+17.0%
  • 2014$2.63B-325.6%
  • 2013−$1.16B-171.6%
  • 2012$1.63B+10.2%
  • 2011$1.48B+1.6%
  • 2010$1.45B+59.6%
  • 2009$909.25M-29.4%
  • 2008$1.29B+74.9%
  • 2007$736.53M+14.6%
  • 2006$642.96M+12.6%
  • 2005$571.13M+59.4%
  • 2004$358.22M-536.7%
  • 2003−$82.03M-716.0%
  • 2002$13.32M-89.0%
  • 2001$120.82M-27.6%
  • 2000$166.82M-10.3%
  • 1999$185.96M+38.5%
  • 1998$134.23M+116.2%
  • 1997$62.08M-425.1%
  • 1996−$19.10M-53.3%
  • 1995−$40.86M+365.2%
  • 1994−$8.78M-123.9%
  • 1993$36.80M+9.2%
  • 1992$33.70M-1448.0%
  • 1991−$2.50M+525.0%
  • 1990−$400.00K-96.2%
  • 1989−$10.60M—

Free Cash Flow values are taken from Biogen's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Free Cash Flow at Biogen (BIIB)

Free Cash Flow for Biogen (BIIB): headline value $2.62B · YoY -18.5%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Biogen (BIIB) free cash flow is $2.05B – declined 18.5% year-over-year.

Across 2020–2025 (5 years), Biogen free cash flow produced a CAGR of -11.6% – with a net decline across the window.

Biogen free cash flow peaked at $6.56B in 2019; the latest annual figure is $2.05B in 2025 (68.8% below peak).

Across the available history, free cash flow reached its high of $6.56B in 2019 and its low of −$1.16B in 2013.

Biogen Free Cash Flow by Year

Biogen Free Cash Flow 2025: $2.05B

Biogen free cash flow in 2025 was $2.05B, declined 18.5% below 2024.

Biogen Free Cash Flow 2024: $2.52B

2024's free cash flow for Biogen came in at $2.52B, surged 103.6% from 2023.

Biogen Free Cash Flow 2023: $1.24B

Biogen posted free cash flow of $1.24B in 2023, grew 8.0% from 2022.

Biogen Free Cash Flow 2022: $1.14B

In 2022, Biogen reported free cash flow of $1.14B, plunged 66.2% below 2021.

Biogen Free Cash Flow 2021: $3.38B

Biogen free cash flow in 2021 was $3.38B.

See more financial history for Biogen (BIIB).

Sector peers by Free Cash Flow

Healthcare peers of Biogen (BIIB), ranked by their latest free cash flow

Frequently asked questions

Biogen (BIIB) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation